Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2018

Sep 26, 2018

30587_dirs_2018-09-26_fe56c4df-5331-4c8a-b2fc-90892b59a238.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Urovant Sciences Ltd. (UROV)
CIK: 0001740547
Period of Report: 2018-09-26

Reporting Person: Roivant Sciences Ltd. (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares, $0.000037453 par value per share 20025098 Direct